Global Nanotechnology Drug Delivery Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 150553
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 123
  • list Pharmaceuticals and Healthcare

Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e. nano-technology), resulting in a number of products, including therapeutics and imaging agents, enabling more effective and less toxic therapeutic and diagnostic interventions.

Scope of the Report:

This report studies the Nanotechnology Drug Delivery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nanotechnology Drug Delivery market by product type and applications/end industries.

Nanotechnology drug delivery is a growing field and is witnessing increasing acceptance in health care applications. Nanotechnology drug delivery is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. One important and active application area of nanotechnology drug delivery systems is to transport drugs to the final location of therapeutic intervention within the body.

The global Nanotechnology Drug Delivery market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nanotechnology Drug Delivery.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

AbbVie, Inc.

Amgen Inc.

Celgene Corporation

Johnson & Johnson

Merck & Co., Inc.

Novartis International AG

Perrigo Company plc

Pfizer, Inc.

Teva Pharmaceutical Industries Ltd.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Nanocrystals

Nanoparticles

Liposomes

Micelles

Nanotubes

Others

Market Segment by Applications, can be divided into

Neurology

Oncology

Cardiovascular/Physiology

Anti-inflammatory/Immunology

Anti-infective

Other Applications

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Nanotechnology Drug Delivery Market Overview

1.1 Product Overview and Scope of Nanotechnology Drug Delivery

1.2 Classification of Nanotechnology Drug Delivery by Types

1.2.1 Global Nanotechnology Drug Delivery Revenue Comparison by Types (2017-2023)

1.2.2 Global Nanotechnology Drug Delivery Revenue Market Share by Types in 2017

1.2.3 Nanocrystals

1.2.4 Nanoparticles

1.2.5 Liposomes

1.2.6 Micelles

1.2.7 Nanotubes

1.2.8 Others

1.3 Global Nanotechnology Drug Delivery Market by Application

1.3.1 Global Nanotechnology Drug Delivery Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Neurology

1.3.3 Oncology

1.3.4 Cardiovascular/Physiology

1.3.5 Anti-inflammatory/Immunology

1.3.6 Anti-infective

1.3.7 Other Applications

1.4 Global Nanotechnology Drug Delivery Market by Regions

1.4.1 Global Nanotechnology Drug Delivery Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Nanotechnology Drug Delivery Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Nanotechnology Drug Delivery Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nanotechnology Drug Delivery Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Nanotechnology Drug Delivery Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nanotechnology Drug Delivery Status and Prospect (2013-2023)

1.5 Global Market Size of Nanotechnology Drug Delivery (2013-2023)

2 Manufacturers Profiles

2.1 AbbVie, Inc.

2.1.1 Business Overview

2.1.2 Nanotechnology Drug Delivery Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.2 Amgen Inc.

2.2.1 Business Overview

2.2.2 Nanotechnology Drug Delivery Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Amgen Inc. Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.3 Celgene Corporation

2.3.1 Business Overview

2.3.2 Nanotechnology Drug Delivery Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Celgene Corporation Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.4 Johnson & Johnson

2.4.1 Business Overview

2.4.2 Nanotechnology Drug Delivery Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Johnson & Johnson Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.5 Merck & Co., Inc.

2.5.1 Business Overview

2.5.2 Nanotechnology Drug Delivery Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.6 Novartis International AG

2.6.1 Business Overview

2.6.2 Nanotechnology Drug Delivery Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Novartis International AG Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.7 Perrigo Company plc

2.7.1 Business Overview

2.7.2 Nanotechnology Drug Delivery Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Perrigo Company plc Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.8 Pfizer, Inc.

2.8.1 Business Overview

2.8.2 Nanotechnology Drug Delivery Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Pfizer, Inc. Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.9 Teva Pharmaceutical Industries Ltd.

2.9.1 Business Overview

2.9.2 Nanotechnology Drug Delivery Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

3 Global Nanotechnology Drug Delivery Market Competition, by Players

3.1 Global Nanotechnology Drug Delivery Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Nanotechnology Drug Delivery Players Market Share

3.2.2 Top 10 Nanotechnology Drug Delivery Players Market Share

3.3 Market Competition Trend

4 Global Nanotechnology Drug Delivery Market Size by Regions

4.1 Global Nanotechnology Drug Delivery Revenue and Market Share by Regions

4.2 North America Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

4.3 Europe Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

4.5 South America Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

5 North America Nanotechnology Drug Delivery Revenue by Countries

5.1 North America Nanotechnology Drug Delivery Revenue by Countries (2013-2018)

5.2 USA Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

5.3 Canada Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

5.4 Mexico Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

6 Europe Nanotechnology Drug Delivery Revenue by Countries

6.1 Europe Nanotechnology Drug Delivery Revenue by Countries (2013-2018)

6.2 Germany Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

6.3 UK Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

6.4 France Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

6.5 Russia Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

6.6 Italy Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Nanotechnology Drug Delivery Revenue by Countries

7.1 Asia-Pacific Nanotechnology Drug Delivery Revenue by Countries (2013-2018)

7.2 China Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

7.3 Japan Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

7.4 Korea Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

7.5 India Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

8 South America Nanotechnology Drug Delivery Revenue by Countries

8.1 South America Nanotechnology Drug Delivery Revenue by Countries (2013-2018)

8.2 Brazil Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

8.3 Argentina Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

8.4 Colombia Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Nanotechnology Drug Delivery by Countries

9.1 Middle East and Africa Nanotechnology Drug Delivery Revenue by Countries (2013-2018)

9.2 Saudi Arabia Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

9.3 UAE Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

9.4 Egypt Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

9.5 Nigeria Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

9.6 South Africa Nanotechnology Drug Delivery Revenue and Growth Rate (2013-2018)

10 Global Nanotechnology Drug Delivery Market Segment by Type

10.1 Global Nanotechnology Drug Delivery Revenue and Market Share by Type (2013-2018)

10.2 Global Nanotechnology Drug Delivery Market Forecast by Type (2018-2023)

10.3 Nanocrystals Revenue Growth Rate (2013-2023)

10.4 Nanoparticles Revenue Growth Rate (2013-2023)

10.5 Liposomes Revenue Growth Rate (2013-2023)

10.6 Micelles Revenue Growth Rate (2013-2023)

10.7 Nanotubes Revenue Growth Rate (2013-2023)

10.8 Others Revenue Growth Rate (2013-2023)

11 Global Nanotechnology Drug Delivery Market Segment by Application

11.1 Global Nanotechnology Drug Delivery Revenue Market Share by Application (2013-2018)

11.2 Nanotechnology Drug Delivery Market Forecast by Application (2018-2023)

11.3 Neurology Revenue Growth (2013-2018)

11.4 Oncology Revenue Growth (2013-2018)

11.5 Cardiovascular/Physiology Revenue Growth (2013-2018)

11.6 Anti-inflammatory/Immunology Revenue Growth (2013-2018)

11.7 Anti-infective Revenue Growth (2013-2018)

11.8 Other Applications Revenue Growth (2013-2018)

12 Global Nanotechnology Drug Delivery Market Size Forecast (2018-2023)

12.1 Global Nanotechnology Drug Delivery Market Size Forecast (2018-2023)

12.2 Global Nanotechnology Drug Delivery Market Forecast by Regions (2018-2023)

12.3 North America Nanotechnology Drug Delivery Revenue Market Forecast (2018-2023)

12.4 Europe Nanotechnology Drug Delivery Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Nanotechnology Drug Delivery Revenue Market Forecast (2018-2023)

12.6 South America Nanotechnology Drug Delivery Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Nanotechnology Drug Delivery Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Nanotechnology Drug Delivery Picture

Table Product Specifications of Nanotechnology Drug Delivery

Table Global Nanotechnology Drug Delivery and Revenue (Million USD)

Please fill the form below, to recieve the report sample


+1